The term phase iii clinical trial is identified in base64 scheme by the sequence cGhhc2UgaWlpIGNsaW5pY2FsIHRyaWFs, while the MD5 signature is equal to ad1eb0607640ff09cd9b66c47eadc0d6. The ASCII encoding of phase iii clinical trial in hexadecimal notation is 70686173652069696920636c696e6963616c20747269616c.